Literature DB >> 25301649

Draft Whole-Genome Sequences of Three Shiga Toxin-Producing Escherichia coli O91:H21 Isolates, Two from Hemolytic Uremic Syndrome Patients and One of Porcine Origin.

Cindy H Wu1, Peng Zhang2, Christina Q Morales2, David Kiang1.   

Abstract

This study presents three genomes of O91:H21 isolates, two from hemolytic uremic syndrome patients and one of porcine origin. Genome analyses reveal that one of the human isolates contains both Shiga toxin-encoding genes (stx1 and stx2), and all three isolates contain putative adhesin (iha and eaeH) and antibiotic resistance (ampC) genes.
Copyright © 2014 Wu et al.

Entities:  

Year:  2014        PMID: 25301649      PMCID: PMC4192381          DOI: 10.1128/genomeA.01000-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Non-O157 Shiga-toxin-producing E. coli (STEC) species are important emerging pathogens due to the rise of STEC-related illnesses worldwide (1). In 2011, an outbreak involving STEC O104:H4 led to 3,801 reported cases, and 46 deaths in Germany (2). Next-generation sequencing revealed STEC O104:H4 to be an enteroaggregative E. coli that acquired a Shiga-toxin gene associated with enterohemorrhagic E. coli strains (2, 3). The Germany outbreak illustrated that whole genome characterization is paramount for improving our understanding of genetic transfer among STEC strains and may lead to shortened response times. STEC O91:H21 may progress to hemolytic uremic syndrome (HUS) in humans and has been implicated in outbreaks (4). Previous gene-specific characterizations revealed insights into its pathology and virulence (5–11). However, without whole-genome characterization, its pathogenic mode of action remains unclear. We obtained three O91:H21 isolates from the Michigan State University STEC Library Collection: two HUS patient isolates (H1 and H2) and one pork isolate (P). Whole-genome sequencing was performed using an Ion PGM (Thermo Fisher Scientific, Waltham, MA). Comparative analysis will be used to elucidate genomic differences among the isolates and potential influences on pathogenicity. Genomic DNA was extracted from overnight culture using a DNAeasy blood and tissue kit (Qiagen, Valencia, CA). The genomes were sequenced on the Ion PGM (Thermofisher), and MIRA (v4.0.5) (12) was used for de novo assembly of the contigs. The assembly results for each isolate are as follows: H1, 292 contigs, average coverage of 23×, contig N50 of 40,255 bp, and genome size of 5,068,406 bp; H2, 133 contigs, average coverage of 32×, contig N50 of 140,146 bp, and genome size of 5,039,473 bp; P, 99 contigs, average coverage of 36×, contig N50 of 166,484 bp, and genome size of 4,982,843 bp. The G+C contents for isolates range from 46.6% to 51.5%. The contigs were annotated using the CLC Genomic WorkBench Genome Finishing Module 1.3 (Qiagen, Boston, MA). H1 contains Shiga-toxin encoding genes, stx1 and stx2, whereas H2 and P only have stx2. H1 and H2 contain hemolysin gene, hlyA. All three isolates contain the antibiotic resistance gene, ampC. It is widely documented that this serogroup does not harbor intimin (eae) (13–16), and that other genes may contribute to attachment and effacing of host cells. Interestingly, our analysis reveals the presence of putative adhesin/intimin genes, iha and eaeH, in all three isolates. GenBank BLAST alignment indicates that the O91:H21 eaeH gene has 99.4% identity similarity to the German outbreak strain O104:H4 (CP003289) and 98.1% similarity to an enterotoxigenic E. coli strain E24377A (CU928145). Comparative analysis of whole genome sequences from these three isolates could provide insights into attributes of potentially re-emerging STEC strains and further reveal the influence of genomic differences on virulence. Observations from the comparison will be the focus of a future publication.

Nucleotide sequence accession numbers.

GenBank accession numbers for the sequences are JNNI00000000 (H1), JNNJ00000000 (H2), and JNNL00000000 (P).
  15 in total

1.  Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.

Authors:  A W Paton; P Srimanote; M C Woodrow; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  S D Tyler; W M Johnson; H Lior; G Wang; K R Rozee
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

3.  Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults.

Authors:  R Bonnet; B Souweine; G Gauthier; C Rich; V Livrelli; J Sirot; B Joly; C Forestier
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

4.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates.

Authors:  Martina Bielaszewska; Franziska Stoewe; Angelika Fruth; Wenlan Zhang; Rita Prager; Jens Brockmeyer; Alexander Mellmann; Helge Karch; Alexander W Friedrich
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

6.  Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes.

Authors:  Lothar Beutin; Angelika Miko; Gladys Krause; Karin Pries; Sabine Haby; Katja Steege; Nadine Albrecht
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

7.  Repression of type-1 fimbriae in Shiga toxin-producing Escherichia coli O91:H21 isolated from asymptomatic human carriers in Korea.

Authors:  Jung-Beom Kim; Kyung-Hwan Oh; Mi-Sun Park; Seung-Hak Cho
Journal:  J Microbiol Biotechnol       Date:  2013-05       Impact factor: 2.351

8.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.

Authors:  A R Melton-Celsa; S C Darnell; A D O'Brien
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Authors:  Alexander Mellmann; Dag Harmsen; Craig A Cummings; Emily B Zentz; Shana R Leopold; Alain Rico; Karola Prior; Rafael Szczepanowski; Yongmei Ji; Wenlan Zhang; Stephen F McLaughlin; John K Henkhaus; Benjamin Leopold; Martina Bielaszewska; Rita Prager; Pius M Brzoska; Richard L Moore; Simone Guenther; Jonathan M Rothberg; Helge Karch
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

10.  Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91.

Authors:  Alexander Mellmann; Angelika Fruth; Alexander W Friedrich; Lothar H Wieler; Dag Harmsen; Dirk Werber; Barbara Middendorf; Martina Bielaszewska; Helge Karch
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.